Nalu Bio

Nalu Bio is unlocking the potential of the Endocannabinoid System (ECS), the body’s largest receptor network and a key regulator of inflammation, immune response, and metabolic health. Through its AI-enabled drug discovery platform, the company is building a pipeline of non-addictive therapeutics, starting with endometriosis and post-surgical pain.